Articles

Market insight: AI and causal machine learning are accelerating discovery and more

The power of causal machine learning allows us to apply sophisticated algorithms directly to massive and complex data and accelerate the discovery of cause-and-effect relationships
Written byColin Hill and GNS Healthcare
| 4 min read

Imagine if we could approach healthcare with the precision that retailers like Amazon and Netflix use to reach their customers. Imagine if we could grasp the holy grail of precision medicine and harness the ability to match patients with the specific treatment or intervention that is most effective for them as individuals.

How can we scale precision medicine so that every patient is provided with a personally optimized treatment plan? How can we turn data into models of disease progression and drug response, so we can discover novel biomarkers and accelerate drug discovery and development?

We no longer need to imagine. These questions can be answered through the application of causal machine learning, a powerful type of artificial intelligence that allows data scientists to glean insights directly from all types of data without needing to test hypothesis after hypothesis after hypothesis.

The power of causal machine learning allows us to apply sophisticated algorithms directly to massive and complex data and accelerate the discovery of cause-and-effect relationships. This then enables healthcare organizations to answer questions about underlying causes, as well as run simulations that answer questions like “what will happen if…?”

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Published In

Volume 15 - Issue 1 | January 2019

January 2019

January 2019 Issue

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
3D illustration of a protein complex composed of clustered spherical subunits arranged in a ring-like oligomeric structure, shown in shades of blue, cyan, and purple against a blue gradient background.
Automated mass photometry helps reveal the complex dynamics of protein oligomerization and the factors that govern protein assembly.
A 3D rendering illustrates a sandwich ELISA technique, where antigen detection is achieved between two layers of antibodies: a capture antibody and a detection antibody
Learn the key characteristics that determine whether an immunoassay generates accurate and reproducible data.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue